Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: CISPLATIN - THERAPEUTIC USE , . Treffer: 13
2022
Terbuch, A; Posch, F; Bauernhofer, T; Jost, PJ; Partl, R; Stranzl-Lawatsch, H; Baciarello, G; Fizazi, K; Giannatempo, P; Verzoni, E; Sweeney, C; Ravi, P; Tran, B; Basso, U; White, J; Vincenzi, B; Oing, C; Cutuli, HJ; Dieckmann, KP; Gamulin, M; Chovanec, M; Fankhauser, CD; Heidenreich, A; Mohamad, O; Thibault, C; Fischer, S; Gillessen, S, , International, Germ, Cell, Cancer, Collaborative, Group
Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2022; 113(4):825-832
Doi: 10.1016/j.ijrobp.2022.03.021
Web of Science
PubMed
FullText
FullText_MUG
2014
Hofmann, H; von Haken, R; Werner, J; Kortes, N; Bergmann, F; Schemmer, P; Jäger, D; Radeleff, B; Schulze-Bergkamen, H
Unresectable isolated hepatic metastases from solid pseudopapillary neoplasm of the pancreas: a case report of chemosaturation with high-dose melphalan.
Pancreatology. 2014; 14(6):546-549
Doi: 10.1016/j.pan.2014.08.006
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Ma, X; Rousseau, V; Sun, H; Lantuejoul, S; Filipits, M; Pirker, R; Popper, H; Mendiboure, J; Vataire, AL; Le Chevalier, T; Soria, JC; Brambilla, E; Dunant, A; Hainaut, P; IALT-Bio working group
Significance of TP53 mutations as predictive markers of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer.
Mol Oncol. 2014; 8(3):555-564
Doi: 10.1016/j.molonc.2013.12.015
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2010
Voortman, J; Goto, A; Mendiboure, J; Sohn, JJ; Schetter, AJ; Saito, M; Dunant, A; Pham, TC; Petrini, I; Lee, A; Khan, MA; Hainaut, P; Pignon, JP; Brambilla, E; Popper, HH; Filipits, M; Harris, CC; Giaccone, G
MicroRNA Expression and Clinical Outcomes in Patients Treated with Adjuvant Chemotherapy after Complete Resection of Non-Small Cell Lung Carcinoma.
Cancer Res. 2010; 70(21): 8288-8298.
Doi: 10.1158/0008-5472.CAN-10-1348
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
2007
Filipits, M; Pirker, R; Dunant, A; Lantuejoul, S; Schmid, K; Huynh, A; Haddad, V; André, F; Stahel, R; Pignon, JP; Soria, JC; Popper, HH; Le Chevalier, T; Brambilla, E
Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program.
J Clin Oncol. 2007; 25(19): 2735-2740.
Doi: 10.1200/JCO.2006.08.2867
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
2006
Betticher, DC; Hsu Schmitz, SF; Tötsch, M; Hansen, E; Joss, C; von Briel, C; Schmid, RA; Pless, M; Habicht, J; Roth, AD; Spiliopoulos, A; Stahel, R; Weder, W; Stupp, R; Egli, F; Furrer, M; Honegger, H; Wernli, M; Cerny, T; Ris, HB; Swiss Group for Clinical Cancer Research (SAKK)
Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study.
Br J Cancer. 2006; 94(8):1099-1106
Doi: 10.1038/sj.bjc.6603075
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Ugurel, S; Schadendorf, D; Pföhler, C; Neuber, K; Thoelke, A; Ulrich, J; Hauschild, A; Spieth, K; Kaatz, M; Rittgen, W; Delorme, S; Tilgen, W; Reinhold, U; Dermatologic Cooperative Oncology Group
In vitro drug sensitivity predicts response and survival after individualized sensitivity-directed chemotherapy in metastatic melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group.
Clin Cancer Res. 2006; 12(18):5454-5463
Doi: 10.1158/1078-0432.CCR-05-2763
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Wilkinson, PM; Antonopoulos, M; Lahousen, M; Lind, M; Kosmidis, P; EPO-INT-45 Study Group
Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial.
Br J Cancer. 2006; 94(7):947-954
Doi: 10.1038/sj.bjc.6603004
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
2001
Reles, A; Wen, WH; Schmider, A; Gee, C; Runnebaum, IB; Kilian, U; Jones, LA; El-Naggar, A; Minguillon, C; Schönborn, I; Reich, O; Kreienberg, R; Lichtenegger, W; Press, MF
Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer.
Clin Cancer Res. 2001; 7(10):2984-2997
[OPEN ACCESS]
Web of Science
PubMed
FullText
2000
Klein, M; Rosen, A; Lahousen, M; Graf, AH; Rainer, A
The relevance of adjuvant therapy in primary carcinoma of the fallopian tube, stages I and II: irradiation vs. chemotherapy.
Int J Radiat Oncol Biol Phys. 2000; 48(5):1427-1431
Doi: 10.1016%2FS0360-3016%2800%2901381-X
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
1997
Pont, J; Bokemeyer, C; Harstrick, A; Sellner, F; Greinix, H; Stoiber, F
Chemotherapy for germ cell tumors relapsing after high-dose chemotherapy and stem cell support: a retrospective multicenter study of the Austrian Study Group on Urologic Oncology.
Ann Oncol. 1997; 8(12):1229-1234
Doi: 10.1023/A:1008286305312
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
1990
Petru, E; Boike, G; Sevin, BU
Potentiation of cisplatin cytotoxicity by methylxanthines in vitro.
J Cancer Res Clin Oncol. 1990; 116(5):431-433
Doi: 10.1007/BF01612988
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
1985
Jakse, R; Steindorfer, P; Germann, R; Kraft-Kinz, J; Hackl, A; Schneider, G; Scherlacher, A
Initial results of hyperthermia in palliative therapy of cancers in the ENT area].
Laryngol Rhinol Otol (Stuttg). 1985; 64(2):52-57
Doi: 10.1055/s-2007-1008086
Web of Science
PubMed
FullText
FullText_MUG